lifestyle.thedishh.com

Author: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit

March 9, 2026
Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

March 4, 2026
Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments

March 2, 2026
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

February 10, 2026
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

February 9, 2026
Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

January 21, 2026